Clinical Trial Update: Remifentanil/Sufentanil for CABG+/-AVR Evaluated by Recovery, Cognitive Function, Haemodynamics and Biochemical Markers. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating remifentanil and sufentanil use during CABG with or without aortic valve replacement, assessing recovery, cognitive function, haemodyna…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis
• Ischaemic Heart Disease

Drugs mentioned

• Remifentanil (remifentanil)
• Sufentanil (sufentanil)

Snippet

Sponsor: Aarhus University Hospital | Conditions: Ischaemic Heart Disease, Aortic Stenosis | Phase 4 | Status: COMPLETED